Pawel Marcin Wisniewski
Director/Board Member chez PURE BIOLOGICS S.A.
Profil
Pawel Marcin Wisniewski is currently serving as the Vice Chairman-Management Board at Helix Immuno-Oncology SA. He is also the Deputy Chairman-Supervisory Board at Pure Biologics SA and the Vice President-Management Board at 4cell Therapies SA. Previously, he held the position of Chief Executive Officer at Helix Polska Sp zoo and worked as a Project Manager at Adiuvo Investments SA from 2012 to 2016.
Postes actifs de Pawel Marcin Wisniewski
| Sociétés | Poste | Début |
|---|---|---|
| PURE BIOLOGICS S.A. | Director/Board Member | 26/05/2023 |
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Corporate Officer/Principal | - |
Anciens postes connus de Pawel Marcin Wisniewski
| Sociétés | Poste | Fin |
|---|---|---|
Helix Polska Sp zoo
 Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PURE BIOLOGICS S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Helix Polska Sp zoo
Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland. | Health Technology |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
